Overview
Meng Xu practices practicing medicine in Beijing, China.
His clinical expertise encompasses Hairy Cell Leukemia (HCL), Paraplegia, Melanoma, and Neuroendocrine Tumor.
He is actively involved in clinical research, co-authoring 46 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Meng M. Xu
Is Meng M. Xu a top-rated expert for Hairy Cell Leukemia (HCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Meng M. Xu is classified as an Experienced expert for Hairy Cell Leukemia (HCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Meng M. Xu participate in research or clinical trials?
Yes. Meng M. Xu has published 46 articles and abstracts on conditions like Hairy Cell Leukemia (HCL). You can view a list of Meng M. Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hairy Cell Leukemia (HCL)Mr. Xu isExperienced. Learn about Hairy Cell Leukemia (HCL).
- MelanomaMr. Xu isExperienced. Learn about Melanoma.
- Neuroendocrine TumorMr. Xu isExperienced. Learn about Neuroendocrine Tumor.
- ParaplegiaMr. Xu isExperienced. Learn about Paraplegia.